La Kenya Williams, PhD
About La Kenya Williams, PhD
La Kenya Williams, PhD, is the Associate Director at Bristol-Myers Squibb, specializing in bioanalytical sciences for cardiovascular, oncology, and immuno-oncology assets. She also owns Coaching Endeavors in New Jersey.
Current Role at Bristol-Myers Squibb
La Kenya Williams, PhD, currently serves as an Associate Director at Bristol-Myers Squibb. In this role, she acts as the bioanalytical expert for numerous cardiovascular, oncology, and immuno-oncology assets. Additionally, she leads a team of 13 scientists who are responsible for GxP compliance, bioanalytical assay validation, and sample analysis to evaluate biomarkers, drugs, and the detection of antibodies, all of which support regulatory submissions.
Previous Experience at Bristol-Myers Squibb
La Kenya Williams has held various roles at Bristol-Myers Squibb over several years. She was a Group Leader from 2017 to 2019, a Senior Research Investigator II from 2015 to 2017, a Senior Research Investigator I from 2013 to 2015, and a Research Investigator II from 2011 to 2013. These roles were all based in Lawrenceville, New Jersey. Her tenure at the company has provided her with extensive experience in bioanalytical sciences and the biopharmaceutical industry.
Educational Background
La Kenya Williams holds a Doctorate in Chemistry from Texas A&M University, where she studied from 2000 to 2007. She also completed a Professional Coaching Certificate in Life and Relationship Coaching at the Institute for Professional Excellence in Coaching (iPEC) from 2012 to 2013. This diverse educational background has equipped her with both scientific expertise and skills in professional coaching.
Other Professional Roles
In addition to her current role at Bristol-Myers Squibb, La Kenya Williams is also the Business Owner of Coaching Endeavors in New Jersey. Her previous professional experience includes serving as a Senior Research Scientist at PPD, a Project Manager at Tandem Labs (A LabCorp Company), and holding various roles at Huntingdon Life Sciences, including Study Manager and Research Scientist.
Leadership and Compliance in Bioanalytical Sciences
La Kenya Williams designs and executes a risk-based compliance strategy within Bioanalytical Sciences to ensure that 21 CFR Part 11 and 58 compliance is maintained. She leads her team in thorough validations and qualifications for biomarker, pharmacokinetic (PK), anti-drug antibody (ADA), and cell-based neutralizing antibody (NAB) assays. Her work supports evolving health authority and industry standards. Additionally, she serves as a BAS Representative for cardiovascular, oncology, and immuno-oncology programs, ensuring that bioanalytical assays meet the specific needs of these programs.